NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/26/2025
Back to search
Official data from USPTO
ORLANCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ORLANCE
ST13
US500000090507936Class
5, 10, 42
Filing
90507936
Registration
7922033
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
08/27/2025
Trademark type
Word
Nice classes
5, 10, 42
Filing date
02/03/2021
Registration date
08/26/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/26/2025
Last transaction
08/27/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2024-02-00
First use in commerce
2024-02-00
Drawing code
4
Owner type
03
Owner location
Seattle, WA
Examiner
EULIN, INGRID
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Orlance, Inc.
Representatives
Connie L. Ellerbach FENWICK & WEST LLP
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines; vaccine preparations; medical preparations for the treatment of infectious diseasesrespiratory diseasesmucosal diseasestumorscancer; pharmaceutical preparations and substances for the treatment of diseases and disordersinfectious diseasesrespiratory diseasesmucosal diseasescancer; chemical preparations for the treatment of diseases affecting mucosal tissuesthe immune systemrespiratory tissues; chemical preparations for pharmaceutical purposesforinfectious diseasesrespiratory diseasesmucosal diseasestumorscancer; chemical preparations for medical purposesfor autoimmune diseasesinfectious diseasesrespiratory diseasesmucosal diseasestumorscancer
Class 10
Medical devices to treat autoimmune diseasesinfectious diseasesrespiratory diseasesmucosal diseasesmultiple sclerosistype 1 diabetestumorscancer; medical devices for administering vaccines pneumatically and parts thereof; vaccine apparatus comprised of devices for administering vaccines pneumatically; vaccine apparatusautomatic vaccination apparatus
Class 42
Research and development of vaccines; research and development of medicinesnamely pharmaceutical research and development; research and development in the field of vaccination apparatus; medical research; scientific research; clinical research in the field of autoimmune diseasesinfectious diseasesrespiratory diseasesmucosal diseasesmultiple sclerosistype 1 diabetesimmunotherapyimmune-oncologychemotherapyanti-tumor agents
Publications
History of USPTO decisions and trademark events.
47 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/26/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/07/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/07/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/05/2025
IUAF
USE AMENDMENT FILED
06/29/2025
EISU
TEAS STATEMENT OF USE RECEIVED
06/29/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/02/2025
EX5G
SOU EXTENSION 5 GRANTED
04/01/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/28/2025
EXT5
SOU EXTENSION 5 FILED
12/13/2024
EEXT
SOU TEAS EXTENSION RECEIVED
12/13/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/20/2024
EX4G
SOU EXTENSION 4 GRANTED
06/20/2024
EXT4
SOU EXTENSION 4 FILED
06/20/2024
EEXT
SOU TEAS EXTENSION RECEIVED
06/20/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/21/2023
EX3G
SOU EXTENSION 3 GRANTED
12/19/2023
EXT3
SOU EXTENSION 3 FILED
12/19/2023
EEXT
SOU TEAS EXTENSION RECEIVED
12/19/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/22/2023
EX2G
SOU EXTENSION 2 GRANTED
06/20/2023
EXT2
SOU EXTENSION 2 FILED
06/20/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/20/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/23/2022
EX1G
SOU EXTENSION 1 GRANTED
12/21/2022
EXT1
SOU EXTENSION 1 FILED
12/21/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/21/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/28/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/03/2022
PUBO
PUBLISHED FOR OPPOSITION
05/03/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/13/2022
ALIE
ASSIGNED TO LIE
03/27/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/25/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
03/25/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/25/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
03/25/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/25/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/24/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/23/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/23/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/26/2021
GNRT
NON-FINAL ACTION E-MAILED
08/26/2021
CNRT
NON-FINAL ACTION WRITTEN
08/26/2021
DOCK
ASSIGNED TO EXAMINER
08/25/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/06/2021
NWAP
NEW APPLICATION ENTERED
02/06/2021
Continuous trademark protection
Get notified about every new filing that threatens ORLANCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.